Does Modafinil Cause a Crash?
Some people describe feeling unusually tired or sleepy as modafinil’s effects become less noticeable. That experience is often called a “modafinil crash,” but the term can refer to several different things.
Late-day sleepiness, return of an underlying sleep disorder, accumulated sleep pressure, and rebound sleepiness are all possible explanations. These are not necessarily the same as drug withdrawal.
What Does a “Modafinil Crash” Mean?
“Modafinil crash” is not a defined medical diagnosis.
Someone may use the term to describe late-day sleepiness, where the wake-promoting benefit becomes less noticeable after working well earlier.
It can also describe the return of baseline sleepiness. A person taking modafinil for narcolepsy or another condition involving excessive daytime sleepiness may simply notice their original symptoms again as treatment becomes less effective.
Rebound sleepiness is more specific. It refers to an increase in perceived sleepiness after a period of drug-supported wakefulness.
Withdrawal is different. A withdrawal syndrome involves symptoms caused by physiological adaptation to a drug and its subsequent discontinuation.
Does Modafinil Cause Withdrawal When You Stop Taking It?
The U.S. Modafinil in Narcolepsy Multicenter Study Group randomized 271 people with narcolepsy to modafinil 200 mg, modafinil 400 mg, or placebo for nine weeks. A total of 240 participants then entered a two-week discontinuation phase.
When modafinil was withdrawn, excessive daytime sleepiness returned toward pretreatment levels. The investigators did not identify symptoms associated with an amphetamine withdrawal syndrome (U.S. Modafinil in Narcolepsy Multicenter Study Group, 2000).
The Provigil prescribing information reports the same finding: no withdrawal symptoms were observed during 14 days of monitoring after nine weeks of modafinil treatment, although sleepiness returned in patients with narcolepsy (Provigil, 2025).
Moldofsky et al. (2000) reported a similar pattern after longer treatment. Participants who had received open-label modafinil for 16 weeks were randomized either to continue treatment or switch to placebo for two weeks. Those switched to placebo became significantly sleepier on objective and subjective measures, while mood did not significantly worsen.
The available discontinuation evidence is therefore more consistent with the return of underlying sleepiness than with a distinct stimulant withdrawal syndrome.
Can Sleepiness Return Later in the Day on Modafinil?
Schwartz et al. (2003) studied 32 people with narcolepsy who responded well to modafinil during the day but continued to experience late-afternoon or evening sleepiness. Split dosing sustained wakefulness later into the day more effectively than some once-daily regimens.
A later study involving 56 patients with residual evening sleepiness found a similar pattern, with split-dose regimens maintaining wakefulness later than 200 mg taken once daily (Schwartz et al., 2005).
These studies involved patients selected because they already experienced residual late-day sleepiness, so they do not show how commonly this occurs among everyone taking modafinil.
They do establish that someone can respond well earlier in the day and still become considerably sleepier later. The studies do not establish that this reflects dopamine depletion, abrupt dopamine transporter disengagement, or withdrawal.
Can Modafinil Cause Rebound Sleepiness?
In a 2025 randomized crossover study, Van Cutsem et al. examined 11 healthy military student pilots during 24 hours of extended wakefulness. Participants received placebo or two 200 mg doses of modafinil, for a total of 400 mg.
Modafinil improved vigilance and reduced subjective sleepiness during the prolonged-wakefulness period. Later in the protocol, however, participants reported greater subjective sleepiness in the modafinil condition than in the placebo condition. The authors described this as a rebound effect.
The study was small, involved healthy military trainees rather than patients being treated for a sleep disorder, used 400 mg of modafinil, and deliberately subjected participants to extended wakefulness.
It therefore provides evidence that subjective rebound sleepiness can occur under some conditions, but it does not establish that routine therapeutic modafinil use commonly causes a rebound crash.
Does Modafinil Prevent Sleep Debt?
Physiological sleep rebound is different from simply feeling sleepier while awake. It involves measurable changes during recovery sleep, including changes in EEG slow-wave activity associated with accumulated sleep pressure.
Bodenmann and Landolt (2010) studied 22 healthy young men during 40 hours of prolonged wakefulness. Participants received two 100 mg doses of modafinil or placebo.
Modafinil reduced the increase in subjective sleepiness during sleep deprivation, but it did not suppress the expected slow-wave activity during recovery sleep.
Modafinil therefore does not remove the physiological need for recovery sleep simply because someone feels more alert while taking it.
MedlinePlus likewise advises that modafinil should not be used as a substitute for adequate sleep.
How Long Does Modafinil Stay in Your System?
A long half-life does not mean someone will feel equally alert for the entire time modafinil remains in the body.
Modafinil has an elimination half-life of roughly 12 to 15 hours, meaning its concentration declines relatively slowly (Wong et al., 1999).
Half-life describes drug elimination, not the exact duration or strength of the wake-promoting effect. A person can therefore notice increasing sleepiness while modafinil is still present in the bloodstream.
What Can Cause Fatigue After Modafinil?
Fatigue after modafinil can have several causes. For someone being treated for excessive daytime sleepiness, return of baseline symptoms is one possibility.
Accumulated sleep pressure is another, particularly if modafinil was used while staying awake longer than usual.
Nighttime sleep disruption can also contribute. Insomnia is a recognized adverse effect of modafinil, and delayed or reduced sleep can leave someone tired the following day.
Other common adverse reactions include headache, nausea, nervousness, anxiety, and dizziness. In pooled placebo-controlled trials summarized in the Provigil prescribing information, headache occurred in 34% of modafinil-treated participants compared with 23% receiving placebo, while insomnia occurred in 5% compared with 1% (Provigil, 2025).
These symptoms may be described informally as part of a “comedown” even when no withdrawal syndrome is present.
When Should Post-Modafinil Fatigue Be Discussed With a Doctor?
Post-modafinil fatigue is worth discussing with the prescribing clinician if it becomes substantially more severe than usual, interferes with normal functioning, persists despite adequate sleep, or appears alongside major changes in how the medication is working.
It is also worth raising if modafinil is interfering with nighttime sleep or if excessive daytime sleepiness remains poorly controlled.
MedlinePlus advises discussing dose or timing changes with the prescriber rather than making them independently.
So, Does Modafinil Cause a Crash?
A post-modafinil slump can be real without representing a classic stimulant withdrawal crash.
The word “crash” does not identify the cause on its own. What matters is whether someone is experiencing the return of their usual sleepiness, an unusual rebound after prolonged wakefulness, accumulated sleep loss, disrupted nighttime sleep, or another effect.
For someone who repeatedly feels markedly worse as modafinil’s effects fade, the pattern itself is more informative than the label.
Frequently Asked Questions
Does modafinil make you more tired when it wears off?
Some people can become noticeably sleepier later in the day even after responding well earlier. That does not by itself show that withdrawal or rebound is occurring.
Can modafinil cause rebound sleepiness?
It has been observed experimentally during prolonged wakefulness, but current evidence is too limited to show how common it is during routine prescribed use.
How long does a modafinil crash last?
There is no established duration because “modafinil crash” is not a defined medical syndrome. Duration depends on what is causing the symptoms.
Does modafinil cause withdrawal?
Controlled therapeutic studies have not identified an amphetamine-like withdrawal syndrome after modafinil discontinuation, although underlying sleepiness can return.
Can modafinil hide sleep deprivation?
It can reduce sleepiness and help sustain wakefulness, but it does not eliminate the body’s need for recovery sleep.
Should you take more modafinil if you feel sleepy later?
Dose and timing changes should be discussed with the prescribing clinician rather than used independently to manage late-day fatigue.
References
Bodenmann, S., & Landolt, H. P. (2010). Effects of modafinil on the sleep EEG depend on Val158Met genotype of COMT. Sleep, 33(8), 1027–1035. https://doi.org/10.1093/sleep/33.8.1027
MedlinePlus. (2024). Modafinil. U.S. National Library of Medicine.
Moldofsky, H., Broughton, R. J., & Hill, J. D. (2000). A randomized trial of the long-term, continued efficacy and safety of modafinil in narcolepsy. Sleep Medicine, 1(2), 109–116. https://doi.org/10.1016/S1389-9457(99)00014-3
Provigil [Prescribing information]. (2025). DailyMed, U.S. National Library of Medicine.
Schwartz, J. R. L., Feldman, N. T., & Bogan, R. K. (2005). Dose effects of modafinil in sustaining wakefulness in narcolepsy patients with residual evening sleepiness. The Journal of Neuropsychiatry and Clinical Neurosciences, 17(3), 405–412. https://doi.org/10.1176/jnp.17.3.405
Schwartz, J. R. L., Feldman, N. T., Bogan, R. K., Nelson, M. T., & Hughes, R. J. (2003). Dosing regimen effects of modafinil for improving daytime wakefulness in patients with narcolepsy. Clinical Neuropharmacology, 26(5), 252–257. https://doi.org/10.1097/00002826-200309000-00009
U.S. Modafinil in Narcolepsy Multicenter Study Group. (2000). Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy. Neurology, 54(5), 1166–1175. https://doi.org/10.1212/WNL.54.5.1166
Van Cutsem, J., Van Puyvelde, M., Van den Berg, N. H., Dessy, E., Detaille, F., Van Rompay, A., Mairesse, O., Drogou, C., Sauvet, F., Neyt, X., Pattyn, N., & Simonelli, G. (2025). Stable interindividual differences in modafinil’s effect on vigilance during sleep deprivation. Frontiers in Pharmacology, 16, 1607444. https://doi.org/10.3389/fphar.2025.1607444
Wong, Y. N., Simcoe, D., Hartman, L. N., Laughton, W. B., King, S. P., McCormick, G. C., & Grebow, P. E. (1999). A double-blind, placebo-controlled, ascending-dose evaluation of the pharmacokinetics and tolerability of modafinil tablets in healthy male volunteers. Journal of Clinical Pharmacology, 39(1), 30–40. https://doi.org/10.1177/00912709922007534
